4-(2-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)aniline

95%

Reagent Code: #177477
fingerprint
CAS Number 82925-02-8

science Other reagents with same CAS 82925-02-8

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 312.41 g/mol
Formula C₁₉H₂₄N₂O₂
badge Registry Numbers
MDL Number MFCD04974539
thermostat Physical Properties
Melting Point 129 °C
Boiling Point 473.7±45.0 °C(Predicted)
inventory_2 Storage & Handling
Density 1.132±0.06 g/cm3(Predicted)
Storage -20°C, Inert Gas

description Product Description

Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds, particularly those targeting neurological and cardiovascular systems. Its structure supports the development of receptor modulators, including agents with potential antihypertensive and neuroregulatory effects. Also employed in the design of novel compounds for studying central nervous system disorders due to its ability to cross the blood-brain barrier. Investigated for use in positron emission tomography (PET) tracer development owing to its favorable binding characteristics and derivatization potential.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 100mg
10-20 days ฿3,000.00
inventory 250mg
10-20 days ฿6,000.00
inventory 1g
10-20 days ฿12,000.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
4-(2-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)aniline
No image available

Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds, particularly those targeting neurological and cardiovascular systems. Its structure supports the development of receptor modulators, including agents with potential antihypertensive and neuroregulatory effects. Also employed in the design of novel compounds for studying central nervous system disorders due to its ability to cross the blood-brain barrier. Investigated for use in positron emission tomography (PET

Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds, particularly those targeting neurological and cardiovascular systems. Its structure supports the development of receptor modulators, including agents with potential antihypertensive and neuroregulatory effects. Also employed in the design of novel compounds for studying central nervous system disorders due to its ability to cross the blood-brain barrier. Investigated for use in positron emission tomography (PET) tracer development owing to its favorable binding characteristics and derivatization potential.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...